Literature DB >> 24054127

Bladder capacity as a predictor of voided continence after failed exstrophy closure.

Eric Z Massanyi1, Bhavik B Shah2, Nima Baradaran3, John P Gearhart2.   

Abstract

OBJECTIVE: To evaluate potential predictors of voided continence among bladder exstrophy patients with a history of a failed closure. PATIENTS AND METHODS: The authors reviewed all patients who underwent a bladder neck reconstruction (BNR) with a history of one or more failed exstrophy closures between 1979 and 2007. The following data were collected for each patient: number of failures, site of surgery, mode of failure, presence of osteotomy, bladder capacity, need for additional procedures, and continence status.
RESULTS: Among patients who underwent successful reclosure following one or more failed closures, 52 patients underwent BNR, and 24 (46%) were continent at last follow-up. Bladder capacity was the only variable predictive of voided continence. The median bladder capacity at the time of BNR differed between those who achieved continence (100 mL) and those who did not (65 mL) (p = 0.005). ROC analysis showed an optimal pre-BNR bladder capacity cutoff for predicting future BNR success of between 80 and 100 mL.
CONCLUSION: As previously shown in patients with successful primary closure of exstrophy, these data suggest that bladder capacity also has predictive value in the success of BNR after failed exstrophy closure.
Copyright © 2013 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bladder exstrophy; Bladder neck reconstruction; Failed closure

Mesh:

Year:  2013        PMID: 24054127     DOI: 10.1016/j.jpurol.2013.08.003

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  1 in total

Review 1.  Contemporary issues relating to transitional care in bladder exstrophy.

Authors:  Fardod O'kelly; Daniel Keefe; Sender Herschorn; Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2018-04       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.